Similarly, FDX1 downregulation promotes tumor progression through coordinated activation of mitophagy and PI3K/AKT signaling linked to excessive ROS production in HCC(Sun et al., 2024). This evidence concerns the gene FDX1 and hepatocellular carcinoma.